HWAM
PTCT icon

Hennion & Walsh Asset Management’s PTC Therapeutics PTCT Stock Holding History

Hennion & Walsh Asset Management’s Portfolio PTCT Stock Details PTCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-24,908
Closed -$927K – 782
2021
Q3 		$927K Sell
24,908
-1,075
-4% -$44.2K 0.05% 367
2021
Q2 		$1.1M Buy
25,983
+59
+0.2% +$2.53K 0.06% 341
2021
Q1 		$1.23M Buy
+25,924
New +$1.54M 0.07% 316

Other funds holding PTCT

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Hennion & Walsh Asset Management's PTCT Position: Q4 2021 in Review

Hennion & Walsh Asset Management sold out of PTC Therapeutics (PTCT) in Q4 2021, closing a stake of 24,908 shares — an estimated $927K sold.

Hennion & Walsh Asset Management first reported a position in PTCT in Q1 2021 and held it in 3 quarters. The position peaked at $1.23M in Q1 2021. 178 funds tracked by Wall St. Rank hold PTCT as of Q4 2021.

  • Hennion & Walsh Asset Management reported no remaining PTC Therapeutics position as of Q4 2021 after selling out during the quarter.
  • Hennion & Walsh Asset Management sold 24,908 PTC Therapeutics shares in Q4 2021, an estimated $927K.
  • Hennion & Walsh Asset Management first reported a position in PTC Therapeutics in Q1 2021 and held it in 3 quarters.
  • Hennion & Walsh Asset Management's PTC Therapeutics position peaked at $1.23M in Q1 2021.
  • 178 funds tracked by Wall St. Rank held PTC Therapeutics as of Q4 2021.

Based on Hennion & Walsh Asset Management's 13F filing for Q4 2021, filed 14 Feb 2022.